PATENT CLAIM ANALYSIS

Application Number: 16128601
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-01
Patent Classification: ["514", "249000"]

Abstract:
The present invention relates to compositions and methods for controlling glycemia in a mammalian in need thereof. The present invention relates to compositions and methods for the treatment of diabetes and related disorders. More specifically, the present invention relates to novel therapies or combinatorial therapies for diabetes and related disorders, based on compositions controlling the blood glucose level.

Claim (Index 13):
A method for increasing or stimulating glucose uptake in adipocytes and/or muscular cells in a mammalian subject in need thereof, comprising administering to said subject a composition comprising ifenprodil, or a salt, prodrug or sustained release formulation thereof.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 97.0
- Lexical Diversity: 1.8
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15142227', '14698920', '14425926', '16025461', '14014650']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8372167621258647
- 35 USC 102 Novelty (BERT): 0.850175527373023
- Combined Prediction Score: 0.8385126386505806
- Mean Citation Score: 757.778456
- Max Citation Score: 1237.368
- Similarity Product: 1178.9625042285918

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test